Up-modulation of interferon-γ mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells

Immunology

Volumn 98, Issue 3, 1999, Pages 386-392

  Matera, Lina ^a   Contarini, M ^a   Bellone, G ^b   Forno, B ^b   Biglino, A ^b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Hospital of Asti   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PROLACTIN;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; AUTOCRINE COMMUNICATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTRACELLULAR FLUID; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; PROLACTIN; RECOMBINANT PROTEINS; RNA, MESSENGER; STIMULATION, CHEMICAL;

EID: 0032720146     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00893.x     Document Type: Article

References (39)

1. 1. SABHARWAL P., GLASER R., LAFUSE W. et al. (1992) Prolactin synthesized and secreted by human peripheral blood mononuclear cells and autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci USA 89, 7713.
2. 2. HARTMAN D.P., HOLADAY J.W. & BERTON E.W. (1989) Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J 3, 2194.
3. 3. GALA R.R. (1991) Prolactin and growth hormone in the regulation of the immune system. Proc Soc Exp Biol Med 198, 513.
4. 4. KOOUMAN R., HOOGHE PETERS E.L. & HOOGHE R. (1996) Prolactin, growth hormone and insulin-like growth factor-1 in the immune system. Adv Neuroimmunol 63, 377.
5. 5. MATERA L. (1996) Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 59, 599.
6. 6. MATERA L., BELLONE G., LEBRUN J. et al. (1996) Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoral lymphokine-activated killer cells. Immunology 89, 619.
7. 7. CESANO A., OBERHOLTZER E., CONTARINI M., GEUNA M., BELLONE G. & MATERA L. (1994) Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors. Immunopharmacology 28, 67.
8. 8. MATERA L., CESANO A., BELLONE G. & OBERHOLTZER E. (1992) Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B, and NK lymphocytes. Brain Behav Immun 6, 409.
9. 9. GAIDANO G., CONTARINI M., PASTORE C., SAGLIO G. & MATERA L. (1996) AIDS-related Burkitt's-type lymphomas are a target for lymphokine-activated killers induced by interleukin-2 and prolactin. PSEBM 213, 196.
10. 10. BAZAN J.F. & Shared. (1990) Architecture of hormone binding domains in type I and II interferon receptors. Cell 61, 753.
11. 11. O'NEAL K.D. & YU-LEE L.Y. (1993) The proline-rich motif (PRM): a novel feature of the cytokine/hematopoietin receptor super-family. Lymph Cyt Res 12, 309.
12. 12. YU-LEE L.Y. (1997) Molecular actions of prolactin in the immune system. PSEBM 215, 35.
13. 13. CLEVENGER C.V., FREIER D.O. & KLINE J.B. (1998) Prolactin receptor signal transduction in cells of the immune system. J Endocrinol 157, 187.
14. 14. DUNCAN G.S., MTTRÜCKER H.-W., KÄGI D., MATSUYAMA T. & MAK T.W. (1996) The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J Exp Med 184, 2043.
15. 15. TRINCHIERI G. (1989) Biology of natural killer cells. Adv Immunol 47, 187.
16. 16. PERUSSIA B. (1991) Lymphokine activated killer cells, natural killer cells and cytokines. Curr Opin Immunol 3, 49.
17. 17. PROSS H.F., BAINES M.G., RUBIN P., SHRAGGF P. & PETTERSON M.S. (1981) Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cells activity. J Clin Immunol 1, 51.
18. 18. SPANGELO B.L., HALL N.R., ROSS P.C. & GOLDSTEIN A.L. (1987) Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cell mitogenesis by prolactin. Immunopharmacology 14, 11.
19. 19. CHAKRABORTY A., CHAKRABORTY N.G. & CHATTOPADITYAY U. (1996) Prolactin response of NK cells, but not of LAK cells, is deficient in patients with carcinoma of oral cavily and during aging. Int J Cancer 66, 65.
20. 20. WELLS J.A. & DE VOS A.M. (1993) Structure and function of human growth hormone: implication for the hematopoietin. Annu Rev Biophys Mol Struct 22, 329.
21. 21. RUSSEL D.H., KIBLER R., MATRISIAN L., LARSON D.F., POULOS B. & MAGUN B.E. (1985) Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporin. J Immunol 134, 3027.
22. 22. MATERA L., MUCCIOLI G., CESANO A., BELLUSSI G. & GENAZZANI E. (1988) Prolactin receptors on large granular lymphocytes: dual regulation by cyclosporin A. Brain Behav Immun 2, 1.
23. 23. CESARIO T.C., YOUSEM S., CARANDAG G., SADATI N., LE J. & VAZIRI N. (1994) Enhanced yield of gamma interferon in prolactin-treated human peripheral blood mononuclear cells. Proc Soc Exp Biol Med 205, 89.
24. 24. LANIER L.L. (1988) NK cell receptors. Annu Rev Immunol 16, 359.
25. 25. MORETTA A., SIVORI S., PONTE M., MINGARI M.C. & MORETTA L. (1998) Stimulatory receptors in NK and T cells. Curr Top Microbiol Immunol 230, 15.
26. 26. OKAMURA H., KASHIWAMURA S., TSUTSUI H., YOSHIMOTO T. & NAKANISHI K. (1998) Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 10, 259.
27. 27. COSMAN D., KUMAKI S., ANDERSON D., KENNEDY M., EISENMAN J. & PARK L. (1997) Interleukin 15. Biochem Soc Trans 25, 371.
28. 28. IMADA K., BLOOM E.T., NAKAJIMA H. et al. (1998) Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J Exp Med 188, 2067.
29. 29. BERCZI I. (1993) Prolactin, pregnancy and autoimmune disease. J. Rheumatol 20, 1095.
30. 30. WALKER S.E., ALLEN S.H. & MCMURRAY R.W. (1993) Prolactin and autoimmune desease. Trends Endocrinol Metab 4, 147.
31. 31. MOK C.C., LAU C.S., LEE K.W. & WONG R.W. (1998) Hyperprolactinemia in males with systemic lupus erythematosus. J Rheumatol 25, 2357.
32. 32. LARREA F., MARTINEZ-CASTILLO A., CABRERA V. et al. (1997) A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J Clin Endocrinol Metab 82, 3664.
33. 33. CHICANZA I.C., PETROU P., CHAROUSOS G., KINGSLEY G. & PANAY G.S. (1993) Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implication. Br J Rheumatol 32, 445.
34. 34. RISKIND P.N., MASSACESI L., DOOLITTLE T.H. & HAUSER S.L. (1991) The role of prolactin in autoimmune demyclination: suppression of experimental allergic encephalomyelitis by bromocripline. Ann Neurol 29, 542.
35. 35. ROMAGNANI S. (1996) TH1 and TH2 in human diseases. Clin Immunol Immunopathol 80, 225.
36. 36. GELLERSEN B., DIMATTIA G.E., FRIESEN G. & BOHNET H.G. (1989) Regulation of prolactin secretion in the human B-lymphoblastoid cell line IM-9-P3 by dexamethasone but not other regulators of pituitary prolactin secretion. Endocrinology 125, 2853.
37. + T cells in vitro. J Immunol 156, 2406.
38. 38. MELLADO M., LLORENTE M., RODRIGUEZ-FRADE J.M., LUCAS P., MARTINEZ C. & DEL REAL G. (1998) HIV-1 envelope protein gp120 triggers a Th2 response in mice that shifts to Th1 in the presence of human growth hormone. Vaccine 16, 1111.
39. 39. MATERA L., CESANO A., MUCCIOLI G. & VEGLIA F. (1990) Modulatory effect of prolactin on the DNA synthesis rate and NK activity of large granular lymphocytes. Int J Neurosci 51, 265.